Meghana Sathe, M.D. Titles and Appointments Professor Schools Medical School Departments Pediatrics You have reached the Academic Profile. For more information on the doctor and patient care, please visit the clinical profile. Biography Dr. Meghana Sathe is a graduate of Wellesley College and the University of Miami Miller School of Medicine. She completed her internship and residency in Pediatrics and her fellowship in Pediatric Gastroenterology and Nutrition at the University of Texas Southwestern and Children's Medical Center Dallas. Dr. Sathe's clinical interests are general gastroenterology, hepatology and nutrition. She has a special interest in cystic fibrosis and is the co-medical director of the Claude Prestidge Cystic Fibrosis Foundation Clinic at Children's Medical Center Dallas. She also serves on the Medical Advisory Board of The Alagille Syndrome Alliance. In addition to clinical care, Dr. Sathe is the Associate Fellowship Director for Division of Pediatric Gastroenterology and Nutrition. In this capacity, she is actively involved in the education of medical students, residents and fellows through lectures, conferences and curriculum development. Education Medical School University of Miami School of Medicine (2003) Internship UT Southwestern/Children's Medical Center (2004), Pediatrics Residency UT Southwestern/Children's Medical Center (2006), Pediatrics Fellowship UT Southwestern/Children's Medical Center (2009), Pediatric Gastroenterology Research Interest Cystic fibrosis and nutrition Cystic fibrosis associated liver disease Nutrition Publications Corrigendum to “Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis”(Journal of Cystic Fibrosis, (2025), 24, 6, (1043-1050), (S1569199325015292), 10.1016/j.jcf.2025.07.008) Sathe M, Freedman SD, Putman MS, Gallotto R, Clarkin M, Gallotto D, Pierzynowska K, Borowitz D Journal of Cystic Fibrosis 2026 Jan 25 185 Characterization of Pancreatic Cystosis Phenotype in People With Cystic Fibrosis Daves G, Polachek A, Troendle DM, Sathe M Pancreas 2026 55 e323-e324 Results of a clinical trial of ANG003, a non-porcine pancreatic enzyme replacement therapy, in people with cystic fibrosis Sathe M, Freedman SD, Putman MS, Gallotto R, Clarkin M, Gallotto D, Pierzynowska K, Borowitz D Journal of Cystic Fibrosis 2025 Nov 24 1043-1050 Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis Wood W, Pottorff A, Lazar L, Sathe M Journal of Visualized Experiments 2025 Aug 2025-August Improving Modulator Management and Side Effect Screening: A CF Learning Network Innovation Lab Author Collaboration Ft, Lonabaugh KP, Saulitis A, Boettinger E, Brighton D, Akers M, Barber AT, Gifford AH, Kubiak SE, McNamara SC, Ries O, Schulke DF, List R, Shen S, Horton BJ, Albon D, Ong T, Linnemann RW, Dangel G, Gordon R, Joseph M, Lemieux A, Sawicki G, Tran V, Lawrence M, McMahon L, Uluer A, Baxter B, Hazen M, House M, McKinnon M, Pendley S, Robinson W, Amin R, Hjelm M, Miller J, Moore S, Mullen L, Proffitt J, Roach J, Selker N, Siracusa C, Traver K, Wacker M, Garbarz J, Newman E, Pancham K, Poonawala-Manjee S, Renner K, Sathe M, Sharma P Pediatric pulmonology 2025 Jul 60 Validation of dietary whey protein substrate challenge absorption test as an indicator of proteolysis Pierzynowska K, Pierzynowski S, Zaworski K, Gallotto R, Sathe M, Freedman SD, Borowitz D PloS one 2025 May 20 Cystic Fibrosis Learning Network Telehealth Innovation Lab During the COVID-19 Pandemic: Impact on Access to Care, Outcomes, and a New CF Care Model Albon D, Ong T, Horton B, Brighton D, Shen S, List R, Antos N, Asfour F, Balasa E, Beachler D, Daines C, Froh D, Kier C, Nasr S, Sathe M, Sawicki G, Schechter M, Solomon G, Powers M Pediatric pulmonology 2025 May 60 Estimating minimal clinically important difference (MCID) for gastrointestinal symptoms in cystic fibrosis Lee MJ, Sathe M, Moshiree B, Vu PT, Heltshe SL, Schwarzenberg SJ, Freedman SD, Freeman AJ Journal of Cystic Fibrosis 2024 Sep 23 991-999 Remaining barriers to normalcy in cystic fibrosis: Considerations in GI, liver, and nutrition Sathe M, Stein A Pediatric pulmonology 2024 Sep 59 S5 Cystic fibrosis hepatobiliary involvement: an update on imaging in diagnosis and monitoring Wood W, Tinich T, Lazar L, Schooler GR, Sathe M Pediatric radiology 2024 Aug 54 1416-1427 Results 1-10 of 57 1 2 3 4 5 Next Last Books Featured Books Congenital enzyme and transport defects. In Sondheimer J, Hurtado C, eds. The NASPGHAN Fellows Concise Review of Pediatric Gastroenterology, Hepatology and Nutrition. Sathe M. (2011). New York: Castle Connolly. Liver Disease. In Allen J, Panitch H, Rubenstein R, eds. Cystic Fibrosis: Lung Biology in Health and Disease. Vol 242. Sathe M, Feranchak AP. (2010). New York: Informa Healthcare USA. Pediatric Cystic Fibrosis and Fat-Soluble Vitamins. In Watson RS, ed. Diet and Exercise in Cystic Fibrosis. 1st ed. Sathe M, Feranchak AP. (2015). Elsevier Inc. Cystic Fibrosis Associated Liver Disease. In Suchy F, Sokol R, Balistreri W, eds. Liver Disease in Children. 4th ed. Sathe M, Feranchak AP. (2014). Cambridge University Press. Honors & Awards Texas Super DoctorsTexas Monthly (2017-2018) Texas Rising StarsTexas Monthly Magazine (2016) Top Pediatric Specialists/Doctors in DallasD Magazine (2013) (2015-2018) Teaching and Tomorrow Program, 2nd World Congress, Paris, FranceNASPGHAN (2004) Magna Cum Laude, Phi Beta Kappa, Sigma Chi, Wellesley College (1999) Professional Associations/Affiliations American Board of Pediatrics (2006) American Board of Pediatrics, Gastroenterology (2009) Dallas County Medical Society/Texas Medical Society (2012) North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (2006) Pediatric Society of Greater Dallas (2012) Texas Medical Board (2005)
